In vitro drug efficacy evaluation platform | Isolation and cultivation of bacteria/fungi/viruses | |
In vitro antiviral test | Antiviral drug CC50 and EC50 testing | |
In vitro antimicrobial susceptibility test | Determination of minimum inhibitory concentration (MIC) | |
Minimum bactericidal concentration determination (MBC) | ||
FIC assay chessboard method combined with antibacterial ability determination | ||
Sterilization curve determination (KCs) | ||
Evaluation of vaccine immunogenicity | Humoral immune evaluation: IgG, neutralization test, hemagglutination inhibition potency detection | |
Cellular immune evaluation: ELISPOT and flow cytometry detection | ||
|
|
|
In vivo drug efficacy evaluation platform | Virus class | Reproductive tract infection |
Respiratory system infection | ||
Skin system infection | ||
Metabolic system infection | ||
Animal or pet infection evaluation | ||
Bacteria and fungi | Reproductive tract infection | |
Respiratory system infection | ||
Skin system infection | ||
Systemic infection | ||
Muscle infection | ||